Citation Impact

Citing Papers

Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Hepatic stellate cells as key target in liver fibrosis
2017
Mechanisms of hepatic stellate cell activation
2017 Standout
Type III Interferons in Hepatitis C Virus Infection
2016
Hepatocellular carcinoma
2021 Standout
The tumor microenvironment
2020 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Antigen-specific NK cell memory in rhesus macaques
2015
Emerging insights into natural killer cells in human peripheral tissues
2016
Natural killer cells in liver disease
2012
The core of hepatitis C virus pathogenesis
2016
Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity
2019
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Hepatic Stellate Cells in Liver Tumor
2020
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
2016
Cellular and molecular mechanisms in liver fibrogenesis
2014
Innate and adaptive immune responses in HCV infections
2014
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
Immunological memory cells
2018 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Natural history of hepatitis C
2014
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture
2016 StandoutNobel
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Control of Human Viral Infections by Natural Killer Cells
2013
Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection
2016
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
IFN‐λ‐mediated IL‐12 production in macrophages induces IFN‐γ production in human NK cells
2014
Innate immunity in alcoholic liver disease
2011
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Emerging concepts in immunity to hepatitis C virus infection
2013
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel

Works of A Glässner being referenced

Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2
2011
CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients
2014
The CXCR3(+)CD56Bright Phenotype Characterizes a Distinct NK Cell Subset with Anti-Fibrotic Potential That Shows Dys-Regulated Activity in Hepatitis C
2012
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
2012
Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type
2014
An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients
2014
IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C
2016
Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection
2015
Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients
2013
Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
2017
Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis
2012
Rankless by CCL
2026